It has been reported that parkin promotes α- and β-tubulin degradation and that its PD-linked mutations remove this ability [5]; thus, the enrichment of β-tubulin in patients with parkin mutation is not surprising. The gene discussed is PRKN; the disease is Parkinson disease.